124 results
Page 5 of 7
8-K
EX-99.1
koaux89c9 x105f11
19 Aug 21
FDA Completes On-site Pre-Approval Inspection of
4:05pm
8-K
EX-99.1
fgbes
24 May 21
Liquidia Announces Generic Treprostinil Injection Now Also Available for Subcutaneous Route of Administration
4:07pm
10-Q
mgszw5oek2m
13 May 21
Quarterly report
4:02pm
8-K
EX-99.1
g012cs n6
13 May 21
Liquidia Reports First Quarter 2021 Financial Results
7:15am
8-K
EX-99.1
t8rmj wsf2j6uf55
10 May 21
Liquidia Resubmits New Drug Application for LIQ861 (treprostinil) Inhalation Powder for the Treatment of Pulmonary Arterial Hypertension
6:36am
DEF 14A
s0ef23i
30 Apr 21
Definitive proxy
4:28pm
8-K
azoinb4v5b ps
26 Mar 21
Other Events
4:01pm
10-K
qx3ec07fk
25 Mar 21
Annual report
5:01pm
10-K
EX-10.4
2xy5 f106
25 Mar 21
Annual report
5:01pm
10-K
EX-10.23
wq9guzkowl46yzs
25 Mar 21
Annual report
5:01pm
10-K
EX-10.28
shanqr
25 Mar 21
Annual report
5:01pm
8-K
EX-99.1
4hbi 8b8js
23 Mar 21
Results of Operations and Financial Condition
7:41am
8-K12B/A
EX-99.2
erblia
2 Feb 21
Notification of registration of securities (amended)
4:01pm
S-8
7pi8got
2 Feb 21
Registration of securities for employees
8:34am
S-8
EX-5.1
g32jerktpz2l7srfiq9
2 Feb 21
Registration of securities for employees
8:34am
8-K
EX-10.1
gumjg uip51rirg
14 Jan 21
Departure of Directors or Certain Officers
8:48am
S-8
n4uter
5 Jan 21
Registration of securities for employees
5:25pm
S-3
u1camc1os7ib625ux80
16 Dec 20
Shelf registration
5:16pm